Cargando…
Human Vaccines & Immunotherapeutics: News
Two therapeutic HPV vaccine candidates successful in phase 1 Flu shot may prevent heart attacks and stroke CDX-1401 combined with TLR agonist: Positive phase 1 results Three MRSA vaccines in early clincial trials Ovarian cancer vaccine candidate DPX-Survivac: Positive interim results from phase 1 Ch...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656059/ https://www.ncbi.nlm.nih.gov/pubmed/23817319 http://dx.doi.org/10.4161/hv.23373 |
| _version_ | 1782269980252831744 |
|---|---|
| author | Riedmann, Eva M. |
| author_facet | Riedmann, Eva M. |
| author_sort | Riedmann, Eva M. |
| collection | PubMed |
| description | Two therapeutic HPV vaccine candidates successful in phase 1 Flu shot may prevent heart attacks and stroke CDX-1401 combined with TLR agonist: Positive phase 1 results Three MRSA vaccines in early clincial trials Ovarian cancer vaccine candidate DPX-Survivac: Positive interim results from phase 1 Chinese biotech partnership brings first hepatitis E vaccine to the market Therapeutic vaccine for treatment of genital herpes enters phase 2 Visionary concept: Printable vaccines |
| format | Online Article Text |
| id | pubmed-3656059 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | Landes Bioscience |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-36560592013-05-23 Human Vaccines & Immunotherapeutics: News Riedmann, Eva M. Hum Vaccin Immunother News, Policy and Profiles Two therapeutic HPV vaccine candidates successful in phase 1 Flu shot may prevent heart attacks and stroke CDX-1401 combined with TLR agonist: Positive phase 1 results Three MRSA vaccines in early clincial trials Ovarian cancer vaccine candidate DPX-Survivac: Positive interim results from phase 1 Chinese biotech partnership brings first hepatitis E vaccine to the market Therapeutic vaccine for treatment of genital herpes enters phase 2 Visionary concept: Printable vaccines Landes Bioscience 2012-12-01 2012-12-01 /pmc/articles/PMC3656059/ /pubmed/23817319 http://dx.doi.org/10.4161/hv.23373 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
| spellingShingle | News, Policy and Profiles Riedmann, Eva M. Human Vaccines & Immunotherapeutics: News |
| title | Human Vaccines & Immunotherapeutics: News |
| title_full | Human Vaccines & Immunotherapeutics: News |
| title_fullStr | Human Vaccines & Immunotherapeutics: News |
| title_full_unstemmed | Human Vaccines & Immunotherapeutics: News |
| title_short | Human Vaccines & Immunotherapeutics: News |
| title_sort | human vaccines & immunotherapeutics: news |
| topic | News, Policy and Profiles |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656059/ https://www.ncbi.nlm.nih.gov/pubmed/23817319 http://dx.doi.org/10.4161/hv.23373 |
| work_keys_str_mv | AT riedmannevam humanvaccinesimmunotherapeuticsnews |